Investing Profile

Andrew Sinclair

InvestorVC
Partner, Portfolio Manager at Abingworth
Photo of Andrew Sinclair, Partner at Abingworth

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Abingworth Partner
$15.0M - $30.0M
$22.5M
2
$465M
CompanyStageDateRound SizeTotal Raised
Entact Bio
Series ADec 2022$81M
$81M
Co-investors: Owen Smith (4BIO Capital), Richard Gaster (venBio)
Soleno Therapeutics
Post Ipo EquityDec 2018$17M
$17M
Co-investors: Jack Schuler
Partner, Portfolio Manager Abingworth2008 - Present